In a large, multicenter analysis of more than 4500 patients, higher OPG mRNA expression was associated with reduced breast cancer-specific mortality among patients with ER+ tumors (n = 1941), but not among patients with ER– disease (n = 649) [33]. The gene discussed is TNFRSF11B; the disease is breast cancer.